split-virion pandemic influenza vaccine (H5N1 strain NIBRG-14)

BIOLOGICAL2 trials

Sponsors

Sinovac Biotech Co., Ltd

Conditions

Influenza

Phase 2

Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Children

CompletedNCT00900991

Sinovac Biotech Co., LtdInfluenza

Updated: 2009-05-14

Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Adolescents

CompletedNCT00900588

Sinovac Biotech Co., LtdInfluenza

Updated: 2009-08-12